Revance Therapeutics Investor Relations Material
Latest events
Q2 2024
Revance Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Revance Therapeutics Inc
Access all reports
Revance Therapeutics Inc. is a biotechnology company focused on developing and commercializing innovative aesthetic and therapeutic treatments. The company’s portfolio includes Daxxify, a long-lasting botulinum toxin for wrinkle reduction, and other injectable products for aesthetic enhancements. Revance also develops treatments targeting neurological and musculoskeletal disorders. Revance Therapeutics is headquartered in Nashville, Tennessee, and its shares are listed on the NASDAQ.
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
RVNC
Country
🇺🇸 United States